Raymed Labs Ltd. - Research Center
531207 RAYLA Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
-6.58 |
-6.41 |
-6.33 |
-6.26 |
-6.20 |
Secured loans
Unsecured loans
Total
-2.31 |
-2.13 |
0.11 |
0.04 |
0.07 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
Less : current liabilities & provisions
Total net current assets
-2.46 |
-2.29 |
-0.05 |
-0.13 |
-0.10 |
Miscellaneous expenses not written
Total
-2.31 |
-2.13 |
0.11 |
0.04 |
0.07 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
42.74 |
42.74 |
42.74 |
42.74 |
42.74 |